Home › B-Cell Leukemia › Kentucky
B-Cell Leukemia clinical trials in Kentucky
3 studies for B-Cell Leukemia are looking for participants at sites in Kentucky.
Cities in Kentucky
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Louisville
RecruitingPhase 3
Ages 18 to 18 · All sexes · Updated Sep 8, 2026 · NCT07509151A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
- Norton Cancer Institute, St. Matthews Campus, Louisville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Norton Cancer Institute, Louisville
RecruitingPhase 1/2
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.